List of works - Katja Harbst

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population

scientific article

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

scientific article

Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

scientific article published on 01 April 2020

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

scientific article published on 18 May 2011

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

scientific article

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers

scientific article published on 05 August 2009

DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype

scientific article published in 2022

Molecular profiling reveals low- and high-grade forms of primary melanoma

scientific article

Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy.

scientific article published in May 2015

Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns

Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns.

scientific article published in October 2010

Multiregion Whole-Exome Sequencing Uncovers the Genetic Evolution and Mutational Heterogeneity of Early-Stage Metastatic Melanoma

scientific article published on 23 May 2016

Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

scientific article published on 23 November 2017

Pervasive chromosomal instability and karyotype order in tumour evolution

scientific article published on 02 September 2020

Primary melanoma tumors from CDKN2A mutation carriers do not belong to a distinct molecular subclass

scientific article published on 7 July 2014

Tertiary lymphoid structures improve immunotherapy and survival in melanoma

scientific article published on 15 January 2020

Tumor genetic heterogeneity analysis of chronic sun-damaged melanoma

scientific article published on 07 December 2019

List of works by Katja Harbst

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers

DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype

Molecular profiling reveals low- and high-grade forms of primary melanoma

Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy.

Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns

Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns.

Multiregion Whole-Exome Sequencing Uncovers the Genetic Evolution and Mutational Heterogeneity of Early-Stage Metastatic Melanoma

Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

Pervasive chromosomal instability and karyotype order in tumour evolution

Primary melanoma tumors from CDKN2A mutation carriers do not belong to a distinct molecular subclass

Tertiary lymphoid structures improve immunotherapy and survival in melanoma

Tumor genetic heterogeneity analysis of chronic sun-damaged melanoma